先天心脏及腔静脉解剖正常的儿童和年轻成人上腔静脉支架置入
回顾性分析2014至2024年19例无先天性心脏病但因慢性中心静脉通路导致上腔静脉狭窄或闭塞的儿童和年轻成人,行上腔静脉支架置入。技术上21%(4/19)需锐性再通,共置入24枚支架(88%裸金属),1例发生上腔静脉撕裂致血性心包/心脏压塞,经心包引流及跨损伤处第二枚支架处理成功。中位随访15个月,74%(15/19)有影像随访评估支架通畅性,3例需再干预(平均16个月),所有患者维持了所需中心静脉通路。结论认为该技术安全性良好,是维持慢性病患儿关键中心静脉通路的有效方法。
要点
- 无先天性心脏病儿童的上腔静脉支架置入技术成功率高,但21%(4/19)需锐性再通。
- 锐性再通中可发生上腔静脉撕裂致血性心包/心脏压塞,本组1例经心包引流及第二枚支架处理成功。
- 74%(15/19)影像随访评估通畅性,3例需再干预,平均再干预时间16个月。
核心结论
- 无先天性心脏病的儿童和年轻成人行上腔静脉支架置入安全性良好,是维持慢性病患儿必要治疗所需关键中心静脉通路的有效方法。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,纳入2014至2024年无先天性心脏病、因慢性中心静脉通路导致上腔静脉狭窄或闭塞并接受上腔静脉支架置入的儿童和年轻成人19例(女11例、男8例)。
关键影像表现/征象
- 上腔静脉狭窄或闭塞由术前胸部CT或MRI确定,并经静脉造影和血管内超声确认。
- 症状性患者定义为面部或颈部肿胀、颈部或胸壁侧支血管凸起、依赖中心静脉通路且中心静脉通路狭窄或闭塞。
- 10%(2/19)表现为急性上腔静脉综合征。
- 共置入24枚支架,其中21枚(88%)为裸金属支架,3枚为覆膜支架。
- 1例在锐性再通过程中发生上腔静脉撕裂这一主要并发症,导致血性心包/心脏压塞,经心包引流及跨越血管损伤处置入第二枚支架成功治疗。
诊断标准与关键数值
- 上腔静脉狭窄或闭塞由术前胸部CT或MRI确定,并经静脉造影和血管内超声确认。
- 症状性患者定义为面部或颈部肿胀、颈部或胸壁侧支血管凸起、依赖中心静脉通路且中心静脉通路狭窄或闭塞。
- 技术成功、安全性和长期通畅性为本研究评估指标,原文未报告敏感度、特异度、AUC或阈值。
临床应用与阅片要点
- 无先天性心脏病儿童的上腔静脉支架置入可用于维持必要治疗所需的中心静脉通路。
- 锐性再通时需注意上腔静脉撕裂致血性心包/心脏压塞的风险,本组1例经心包引流及第二枚支架处理成功。
- 再干预原因包括允许导管交换的静脉成形术和复发性面部及上肢肿胀的静脉成形术,平均再干预时间16个月。
- 所有患者在研究期间或所需治疗期间维持了中心静脉通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Reports of child and young adult superior vena cava (SVC) stent placement, safety, and long-term patency are limited, particularly in children without congenital heart defects (CHDs).
OBJECTIVE: To characterize technical success, safety, and long-term outcomes of SVC stent placement in children and young adults without co-existing congenital heart defects. Additionally, to demonstrate the ability of SVC stent placement to maintain central venous access in patients with difficult access.
MATERIALS AND METHODS: Institutional Review Board (IRB) approved retrospective review of children and young adults without CHDs who underwent SVC stent placement between 2014 and 2024 was performed. SVC stenosis/occlusion was determined by pre-procedure imaging (chest computed tomography (CT) or magnetic resonance imaging (MRI)), and confirmed with venography and intravascular ultrasound. Symptomatic patients were defined as patients with facial or neck swelling, bulging neck or chest wall collaterals, and dependence on central venous access with narrowed or occluded central venous pathways.
RESULTS: Nineteen patients (n = 11 F, n = 8 M) without CHDs had SVC stents placed. All had SVC stenosis or occlusion secondary to chronic central venous access. Mean age was 16.5 years (3 - 20 years, interquartile range 7.375 years) and mean weight was 50 kg (15.8 - 115.2 kg, interquartile range 32.6 kg). Ten percent (2/19) presented with acute SVC syndrome. In total, 21% (4/19) required sharp recanalization. Twenty-four total stents were placed; 21 (88%) were bare metal and three were covered. One major complication of SVC tearing occurred during sharp recanalization, which led to hemopericardium/cardiac tamponade. This complication was successfully treated with a pericardial drain and deployment of a second stent across the vessel injury. Median patient follow-up time was 15 months (0.5-88 months, interquartile range 53 months). Seventy-four percent (15/19) had imaging follow-up (chest CT or venography) to assess stent patency, with a mean imaging follow-up of 11 months (3 days-86 months, interquartile range 11 months). Three patients required re-intervention(s): two required venoplasty to allow for catheter exchange, and one required venoplasty for recurrent facial and upper extremity swelling. The mean time to re-intervention was 16 months (2-28). There were no complications during repeat interventions. All patients maintained central venous access for the duration of required treatment or throughout the entire study period.
CONCLUSION: SVC stent placement in children and young adults without CHDs has a favorable safety profile and is an effective solution for preserving critical central venous access for necessary therapy in chronically ill children.
引用
- Leshen M, C Matthew H, Shah J, et al. Superior vena cava (SVC) stent placement in children and young adults with congenitally normal cardiac and caval anatomy. Pediatr Radiol. 2025. PMID: 40782253. doi:10.1007/s00247-025-06328-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。